Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Weiss

Showing results (1541-1550 of 2,088) with videos related to

Pageof 209
Sort By:
Journal of Veterinary Medicine. B, Infectious Diseases and Veterinary Public Health|October 26, 2006
Prevalence of genes encoding exfoliative toxins among Staphylococcus hyicus isolated in Russia and GermanyT Kanbar, A V Voytenko, J Alber, et al.
European Journal of Cancer (Oxford, England : 1990)|May 1, 2022
The treatment approach to pediatric non-rhabdomyosarcoma soft tissue sarcomas: a critical review from the INternational Soft Tissue SaRcoma ConsorTiumAndrea Ferrari, Daniel Orbach, Monika Sparber-Sauer, et al.
Gastrointestinal Cancer Research : GCR|March 5, 2009
Multimodality Treatment With Helical Tomotherapy Intensity Modulated Radiotherapy, Capecitabine, and Photodynamic Therapy is Feasible and Well Tolerated in Patients With Hilar CholangiocarcinomaJoseph M Baisden, Michel Kahaleh, Geoffrey R Weiss, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 27, 2002
Phase II trial of recombinant human interleukin-4 in patients with advanced renal cell carcinoma: a southwest oncology group studyRobert P Whitehead, Danika Lew, Robert C Flanigan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 7, 2011
Molecular insights on the peripheral and intratumoral effects of systemic high-dose rIL-2 (aldesleukin) administration for the treatment of metastatic melanomaGeoffrey R Weiss, William W Grosh, Kimberly A Chianese-Bullock, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1986
Use of in vitro dose response effects to select antineoplastics for high-dose or regional administration regimensD D Von Hoff, G M Clark, G R Weiss, et al.
JCI Insight|July 10, 2023
Immunosurveillance shapes the emergence of neo-epitope landscapes of sarcomas, revealing prime targets for immunotherapyDavid O Osei-Hwedieh, Abigail L Sedlacek, Luis Mena Hernandez, et al.
Policy, Politics & Nursing Practice|September 26, 2023
Best Practices for Telehealth in Nurse-Led Care Settings-A Qualitative StudyCharlotte R Weiss, Mia Roberts, Melissa Florell, et al.
Gynecologic Oncology|March 22, 2003
Phase II trial of single agent carboplatin followed by dose-intense paclitaxel, followed by maintenance paclitaxel therapy in stage IV ovarian, fallopian tube, and peritoneal cancers: a Southwest Oncology Group trialMaurie Markman, Tracy Glass, Harriet O Smith, et al.
Medizinische Klinik (Munich, Germany : 1983)|April 1, 1990
[Randomized comparative study of secondary prevention of Pneumocystis carinii pneumonia in patients with acquired immunologic deficiency syndrome]G Höffken, C Elsing, M Ruhnke, et al.
Pageof 209

Showing results (1541-1550 of 2,088) with videos related to

Sort By:
Pageof 209
Journal of Veterinary Medicine. B, Infectious Diseases and Veterinary Public Health|October 26, 2006
Prevalence of genes encoding exfoliative toxins among Staphylococcus hyicus isolated in Russia and GermanyT Kanbar, A V Voytenko, J Alber, et al.
European Journal of Cancer (Oxford, England : 1990)|May 1, 2022
The treatment approach to pediatric non-rhabdomyosarcoma soft tissue sarcomas: a critical review from the INternational Soft Tissue SaRcoma ConsorTiumAndrea Ferrari, Daniel Orbach, Monika Sparber-Sauer, et al.
Gastrointestinal Cancer Research : GCR|March 5, 2009
Multimodality Treatment With Helical Tomotherapy Intensity Modulated Radiotherapy, Capecitabine, and Photodynamic Therapy is Feasible and Well Tolerated in Patients With Hilar CholangiocarcinomaJoseph M Baisden, Michel Kahaleh, Geoffrey R Weiss, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 27, 2002
Phase II trial of recombinant human interleukin-4 in patients with advanced renal cell carcinoma: a southwest oncology group studyRobert P Whitehead, Danika Lew, Robert C Flanigan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 7, 2011
Molecular insights on the peripheral and intratumoral effects of systemic high-dose rIL-2 (aldesleukin) administration for the treatment of metastatic melanomaGeoffrey R Weiss, William W Grosh, Kimberly A Chianese-Bullock, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1986
Use of in vitro dose response effects to select antineoplastics for high-dose or regional administration regimensD D Von Hoff, G M Clark, G R Weiss, et al.
JCI Insight|July 10, 2023
Immunosurveillance shapes the emergence of neo-epitope landscapes of sarcomas, revealing prime targets for immunotherapyDavid O Osei-Hwedieh, Abigail L Sedlacek, Luis Mena Hernandez, et al.
Policy, Politics & Nursing Practice|September 26, 2023
Best Practices for Telehealth in Nurse-Led Care Settings-A Qualitative StudyCharlotte R Weiss, Mia Roberts, Melissa Florell, et al.
Gynecologic Oncology|March 22, 2003
Phase II trial of single agent carboplatin followed by dose-intense paclitaxel, followed by maintenance paclitaxel therapy in stage IV ovarian, fallopian tube, and peritoneal cancers: a Southwest Oncology Group trialMaurie Markman, Tracy Glass, Harriet O Smith, et al.
Medizinische Klinik (Munich, Germany : 1983)|April 1, 1990
[Randomized comparative study of secondary prevention of Pneumocystis carinii pneumonia in patients with acquired immunologic deficiency syndrome]G Höffken, C Elsing, M Ruhnke, et al.
Pageof 209